Aphaia Pharma AG

Clinical trial involving the hospitals from different countries where patients are allocated to two groups of treatment: investigational product or the medicine which looks like the investigational product but doesn’t contain the active substance. The allocation is done by chance and neither Investigator, nor patient will know the group. The purpose of this trial is to evaluate the efficacy and safety of the investigational product. Participants should be diagnosed with obesity.